Crossref journal-article
American Society for Microbiology
Infection and Immunity (235)
Abstract

ABSTRACT Pseudomonas aeruginosa uses a type III secretion system to promote development of severe disease, particularly in patients with impaired immune defenses. While the biochemical and enzymatic functions of ExoU, ExoS, and ExoT, three effector proteins secreted by this system, are well defined, the relative roles of each protein in the pathogenesis of acute infections is not clearly understood. Since ExoU and ExoS are usually not secreted by the same strain, it has been difficult to directly compare the effects of these proteins during infection. In the work described here, several isogenic mutants of a bacterial strain that naturally secretes ExoU, ExoS, and ExoT were generated to carefully evaluate the relative contribution of each effector protein to pathogenesis in a mouse model of acute pneumonia. Measurements of mortality, bacterial persistence in the lung, and dissemination indicated that secretion of ExoU had the greatest impact on virulence while secretion of ExoS had an intermediate effect and ExoT had a minor effect. It is of note that these results conclusively show for the first time that ExoS is a virulence factor. Infection with isogenic mutants secreting wild-type ExoS, ExoS defective in GTPase-activating protein (GAP) activity, or ExoS defective in ADP-ribosyltransferase activity demonstrated that the virulence of ExoS was largely dependent on its ADP-ribosyltransferase activity. The GAP activity of this protein had only a minor effect in vivo. The relative virulence associated with each of these type III effector proteins may have important prognostic implications for patients infected with P. aeruginosa .

Bibliography

Shaver, C. M., & Hauser, A. R. (2004). Relative Contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to Virulence in the Lung. Infection and Immunity, 72(12), 6969–6977.

Authors 2
  1. Ciara M. Shaver (first)
  2. Alan R. Hauser (additional)
References 62 Referenced 271
  1. 10.1128/IAI.68.7.3998-4004.2000
  2. 10.1128/iai.63.4.1541-1551.1995
  3. 10.1128/iai.24.3.837-842.1979
  4. 10.1128/IAI.67.7.3625-3630.1999
  5. 10.1128/IAI.68.1.403-406.2000
  6. 10.1128/IAI.68.5.2916-2924.2000
  7. 10.1006/mpat.2002.0521
  8. 10.1099/00221287-147-10-2659
  9. 10.1046/j.1365-2958.1997.4891851.x
  10. 10.1128/iai.64.6.2288-2294.1996
  11. 10.1128/jb.173.20.6460-6468.1991
  12. 10.1128/IAI.69.9.5318-5328.2001
  13. 10.1046/j.1365-2958.1997.5411905.x
  14. 10.1128/IAI.68.12.7100-7113.2000
  15. 10.1074/jbc.274.51.36369
  16. 10.1097/00003246-200203000-00005
  17. 10.1128/IAI.67.10.5530-5537.1999
  18. 10.1046/j.1365-2958.1998.00727.x
  19. 10.1128/IAI.66.4.1413-1420.1998
  20. 10.1042/bj20020714
  21. 10.1006/plas.1999.1441
  22. 10.1016/S0305-4179(00)00142-X
  23. 10.1046/j.1365-2958.1997.4311793.x
  24. 10.1128/IAI.70.4.2198-2205.2002
  25. 10.1128/iai.63.8.3182-3186.1995
  26. 10.1128/IAI.68.10.6066-6068.2000
  27. 10.1128/IAI.70.1.360-367.2002
  28. Kudoh, I., J. P. Wiener-Kronish, S. Hashimoto, J.-F. Pittet, and D. Frank. 1994. Exoproduct secretions of P. aeruginosa strains influence severity of alveolar epithelial injury. Am. J. Physiol.267(5 Pt. 1):L551-L556. / Am. J. Physiol. (1994)
  29. 10.1172/JCI7124
  30. 10.1038/227680a0
  31. 10.1093/infdis/116.1.112
  32. 10.1021/bi952340g
  33. 10.1128/jb.179.5.1609-1613.1997
  34. 10.1159/000423033
  35. 10.1128/IAI.67.7.3494-3503.1999
  36. 10.1139/m85-074
  37. 10.1007/BF02013593
  38. 10.1159/000410470
  39. 10.1128/iai.45.2.470-474.1984
  40. 10.1128/IAI.67.6.2847-2854.1999
  41. 10.1046/j.1365-2958.1998.01106.x
  42. 10.1046/j.1365-2958.2002.03256.x
  43. 10.1074/jbc.M302472200
  44. 10.1128/IAI.67.3.1508-1510.1999
  45. Reed, L., and J. Muench. 1938. A simple method for estimating fifty percent endpoints. Am. J. Hyg.27:493-497. / Am. J. Hyg. (1938)
  46. 10.1128/IAI.71.9.5296-5305.2003
  47. 10.1086/320737
  48. Sambrook J. E. F. Fritsch and T. Maniatis. 1989. Molecular cloning: a laboratory manual 2nd ed. Cold Spring Harbor Laboratory Press Cold Spring Harbor N.Y.
  49. 10.1093/emboj/cdg290
  50. 10.1038/7391
  51. 10.1086/379372
  52. 10.1016/0378-1119(95)00055-B
  53. 10.1038/nbt1183-784
  54. 10.1128/IAI.72.3.1677-1684.2004
  55. 10.1126/science.1083317
  56. 10.1046/j.1365-2958.1999.01420.x
  57. 10.1016/S0021-9258(18)65874-0
  58. 10.1152/jappl.1993.75.4.1661
  59. 10.1128/jb.179.22.7165-7168.1997
  60. 10.1128/jb.178.5.1412-1419.1996
  61. 10.1046/j.1365-2958.1996.01554.x
  62. 10.1073/pnas.95.23.13899
Dates
Type When
Created 20 years, 9 months ago (Nov. 22, 2004, 7:37 p.m.)
Deposited 3 years, 5 months ago (March 4, 2022, 11:30 p.m.)
Indexed 1 month ago (July 27, 2025, 3:44 a.m.)
Issued 20 years, 8 months ago (Dec. 1, 2004)
Published 20 years, 8 months ago (Dec. 1, 2004)
Published Print 20 years, 8 months ago (Dec. 1, 2004)
Funders 0

None

@article{Shaver_2004, title={Relative Contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to Virulence in the Lung}, volume={72}, ISSN={1098-5522}, url={http://dx.doi.org/10.1128/iai.72.12.6969-6977.2004}, DOI={10.1128/iai.72.12.6969-6977.2004}, number={12}, journal={Infection and Immunity}, publisher={American Society for Microbiology}, author={Shaver, Ciara M. and Hauser, Alan R.}, year={2004}, month=dec, pages={6969–6977} }